TORONTO, Nov. 2, 2018 /CNW/ - Next Edge Capital Corp. ("Next Edge") announced today that, effective on or about November 5, 2018 the risk rating of Next Edge Bio-Tech Plus Fund (the "Fund") will be reduced from "medium to high" to "medium". Next Edge is the manager and trustee of the Fund.
The change is a result of the new risk rating methodology mandated by the Canadian Securities Administrators and an annual review by Next Edge to determine the risk level of its publicly-offered mutual funds.
About Next Edge Capital Corp.
Next Edge Capital Corp. is an alternative investment fund manager and a leader in the structuring and distribution of Liquid Alternative and Private Credit fund products in Canada. Formerly a wholly-owned subsidiary of Man Group plc., the firm is led by a management team responsible for raising over $3 billion of alternative assets since 2000. The firm specializes and focuses on providing unique, non-correlated pooled investment vehicles to the Canadian retail marketplace. Further information can be found at www.nextedgecapital.com.
This press release is for information purposes only and does not constitute an offer to sell or a solicitation to buy the securities referred to herein. This press release is not for dissemination in the United States or for distribution to U.S. news wire services.
SOURCE Next Edge Capital Corp.
For further information: Contact information: Toreigh Stuart, (416) 775-3600, Toreigh.Stuart@nextedgecapital.com